IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
107 hedge funds and large institutions have $1.11B invested in IGM Biosciences in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
+3
Holders Change %
+2.88%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
35
Reduced
32
Closed
13
Calls
$18.7M
Puts
$2.91M
Net Calls
+$15.8M
Net Calls Change
+$14.1M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24.4M |
| 2 |
AG
Artal Group
Luxembourg
|
+$16.4M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.58M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.55M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.39M |
Top Sellers
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$12.6M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$11.6M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$10.2M |
| 4 |
Alkeon Capital Management
New York
|
-$6.75M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.43M |
